Cardio Diagnostics Inc.

0.33
-0.05 (-13.11%)
At close: Mar 31, 2025, 3:34 PM
0.35
3.47%
After-hours: Mar 31, 2025, 07:44 PM EDT
-13.11%
Bid 0.29
Market Cap 17.44M
Revenue (ttm) 74.43K
Net Income (ttm) -17.88M
EPS (ttm) -0.31
PE Ratio (ttm) -1.08
Forward PE -2.09
Analyst Hold
Ask 0.41
Volume 1,943,660
Avg. Volume (20D) 2,346,932
Open 0.36
Previous Close 0.38
Day's Range 0.30 - 0.36
52-Week Range 0.19 - 1.77
Beta 3.56

About CDIO

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois....

Industry Biotechnology
Sector Healthcare
IPO Date Jan 14, 2022
Employees 13
Stock Exchange NASDAQ
Ticker Symbol CDIO
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for CDIO stock is "Hold." The 12-month stock price forecast is $2, which is an increase of 498.09% from the latest price.

Stock Forecasts

Next Earnings Release

Cardio Diagnostics Inc. is scheduled to release its earnings on Apr 11, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription